WINSTON ROY has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a sale of 509 shares of Pacira BioSciences, Inc. ($PCRX) on August 02, 2023.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 2, 2023 | Pacira BioSciences, Inc. | $PCRX | WINSTON ROY | Chief Medical Officer | S | Common Stock | 509 | $34.88 | 52,440.3350 | 46,538,000 | 0.96% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | WINSTON ROY | Chief Medical Officer | A | Common Stock | 10950 | $0.00 | 52,306.0000 | 46,538,000 | 26.48% | 0.02% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | WINSTON ROY | Chief Medical Officer | A | Stock Option (Right to Buy) | 27500 | $0.00 | 27,500.0000 | 46,538,000 | 9999.99% | 0.06% |
| June 6, 2023 | Pacira BioSciences, Inc. | $PCRX | WINSTON ROY | Chief Medical Officer | S | Common Stock | 1779 | $38.99 | 43,213.0000 | 46,538,000 | 3.95% | 0.00% |
| June 7, 2023 | Pacira BioSciences, Inc. | $PCRX | WINSTON ROY | Chief Medical Officer | S | Common Stock | 1857 | $37.87 | 41,356.0000 | 46,538,000 | 4.30% | 0.00% |